世界のDNAワクチン市場予測 2020年-2025年

【英語タイトル】Global DNA Vaccines Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP8443)・商品コード:LPI20AP8443
・発行会社(調査会社):LP Information
・発行日:2020年3月25日(※2024年版があります。お問い合わせください)
・ページ数:133
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「DNAワクチンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、組換えタン性パク質ワクチン、遺伝子性ワクチンなど、用途別には、人間、動物などに区分してまとめた調査レポートです。DNAワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・DNAワクチンの世界市場概要(サマリー)
・DNAワクチンの企業別販売量・売上
・DNAワクチンの企業別市場シェア
・DNAワクチンの世界市場規模 2015年-2020年:種類別(組換えタン性パク質ワクチン、遺伝子性ワクチン)
・DNAワクチンの世界市場規模 2015年-2020年:用途別(人間、動物)
・DNAワクチンの米州市場規模(アメリカ、カナダ、メキシコなど)
・DNAワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・DNAワクチンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・DNAワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・DNAワクチン市場の成長要因・課題・動向
・DNAワクチンの世界市場予測 2021年-2025年
・DNAワクチンの米州市場予測(アメリカ、カナダ、メキシコなど)
・DNAワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・DNAワクチンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・DNAワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・DNAワクチンの世界市場予測:種類別(組換えタン性パク質ワクチン、遺伝子性ワクチン)
・DNAワクチンの世界市場予測:用途別(人間、動物)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the DNA Vaccines market will register a 8.0% CAGR in terms of revenue, the global market size will reach $ 5736.3 million by 2025, from $ 4218.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in DNA Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of DNA Vaccines market by type, application, key manufacturers and key regions and countries.

This study considers the DNA Vaccines value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Recombinant Protein Vaccine
Gene-Based Vaccine

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Human
Animal

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
GSK
Zoties
Elanco
Sanofi
Plumbline Life Sciences
Boehringer-Ingelheim
Indian Immunologicals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global DNA Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of DNA Vaccines market by identifying its various subsegments.
Focuses on the key global DNA Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the DNA Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of DNA Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global DNA Vaccines Consumption 2015-2025
2.1.2 DNA Vaccines Consumption CAGR by Region
2.2 DNA Vaccines Segment by Type
2.2.1 Recombinant Protein Vaccine
2.2.2 Gene-Based Vaccine
2.3 DNA Vaccines Consumption by Type
2.3.1 Global DNA Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global DNA Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global DNA Vaccines Sale Price by Type (2015-2020)
2.4 DNA Vaccines Segment by Application
2.4.1 Human
2.4.2 Animal
2.5 DNA Vaccines Consumption by Application
2.5.1 Global DNA Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global DNA Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global DNA Vaccines Sale Price by Type (2015-2020)

3 Global DNA Vaccines by Company
3.1 Global DNA Vaccines Sales Market Share by Company
3.1.1 Global DNA Vaccines Sales by Company (2018-2020)
3.1.2 Global DNA Vaccines Sales Market Share by Company (2018-2020)
3.2 Global DNA Vaccines Revenue Market Share by Company
3.2.1 Global DNA Vaccines Revenue by Company (2018-2020)
3.2.2 Global DNA Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global DNA Vaccines Sale Price by Company
3.4 Global DNA Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global DNA Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players DNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DNA Vaccines by Regions
4.1 DNA Vaccines by Regions
4.2 Americas DNA Vaccines Consumption Growth
4.3 APAC DNA Vaccines Consumption Growth
4.4 Europe DNA Vaccines Consumption Growth
4.5 Middle East & Africa DNA Vaccines Consumption Growth

5 Americas
5.1 Americas DNA Vaccines Consumption by Countries
5.1.1 Americas DNA Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas DNA Vaccines Value by Countries (2015-2020)
5.2 Americas DNA Vaccines Consumption by Type
5.3 Americas DNA Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC DNA Vaccines Consumption by Regions
6.1.1 APAC DNA Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC DNA Vaccines Value by Regions (2015-2020)
6.2 APAC DNA Vaccines Consumption by Type
6.3 APAC DNA Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe DNA Vaccines by Countries
7.1.1 Europe DNA Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe DNA Vaccines Value by Countries (2015-2020)
7.2 Europe DNA Vaccines Consumption by Type
7.3 Europe DNA Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa DNA Vaccines by Countries
8.1.1 Middle East & Africa DNA Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa DNA Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa DNA Vaccines Consumption by Type
8.3 Middle East & Africa DNA Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 DNA Vaccines Distributors
10.3 DNA Vaccines Customer

11 Global DNA Vaccines Market Forecast
11.1 Global DNA Vaccines Consumption Forecast (2021-2025)
11.2 Global DNA Vaccines Forecast by Regions
11.2.1 Global DNA Vaccines Forecast by Regions (2021-2025)
11.2.2 Global DNA Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global DNA Vaccines Forecast by Type
11.8 Global DNA Vaccines Forecast by Application

12 Key Players Analysis
12.1 Merck
12.1.1 Company Information
12.1.2 DNA Vaccines Product Offered
12.1.3 Merck DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Merck Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 DNA Vaccines Product Offered
12.2.3 GSK DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Zoties
12.3.1 Company Information
12.3.2 DNA Vaccines Product Offered
12.3.3 Zoties DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Zoties Latest Developments
12.4 Elanco
12.4.1 Company Information
12.4.2 DNA Vaccines Product Offered
12.4.3 Elanco DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Elanco Latest Developments
12.5 Sanofi
12.5.1 Company Information
12.5.2 DNA Vaccines Product Offered
12.5.3 Sanofi DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Plumbline Life Sciences
12.6.1 Company Information
12.6.2 DNA Vaccines Product Offered
12.6.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Plumbline Life Sciences Latest Developments
12.7 Boehringer-Ingelheim
12.7.1 Company Information
12.7.2 DNA Vaccines Product Offered
12.7.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Boehringer-Ingelheim Latest Developments
12.8 Indian Immunologicals
12.8.1 Company Information
12.8.2 DNA Vaccines Product Offered
12.8.3 Indian Immunologicals DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Indian Immunologicals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. DNA Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Recombinant Protein Vaccine
Table 5. Major Players of Gene-Based Vaccine
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global DNA Vaccines Consumption Market Share by Type (2015-2020)
Table 8. Global DNA Vaccines Revenue by Type (2015-2020) ($ million)
Table 9. Global DNA Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global DNA Vaccines Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global DNA Vaccines Consumption Market Share by Application (2015-2020)
Table 13. Global DNA Vaccines Value by Application (2015-2020)
Table 14. Global DNA Vaccines Value Market Share by Application (2015-2020)
Table 15. Global DNA Vaccines Sale Price by Application (2015-2020)
Table 16. Global DNA Vaccines Sales by Company (2017-2019) (K Doses)
Table 17. Global DNA Vaccines Sales Market Share by Company (2017-2019)
Table 18. Global DNA Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 19. Global DNA Vaccines Revenue Market Share by Company (2017-2019)
Table 20. Global DNA Vaccines Sale Price by Company (2017-2019)
Table 21. Global DNA Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players DNA Vaccines Products Offered
Table 23. DNA Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global DNA Vaccines Consumption by Regions 2015-2020 (K Doses)
Table 25. Global DNA Vaccines Consumption Market Share by Regions 2015-2020
Table 26. Global DNA Vaccines Value by Regions 2015-2020 ($ Millions)
Table 27. Global DNA Vaccines Value Market Share by Regions 2015-2020
Table 28. Americas DNA Vaccines Consumption by Countries (2015-2020) (K Doses)
Table 29. Americas DNA Vaccines Consumption Market Share by Countries (2015-2020)
Table 30. Americas DNA Vaccines Value by Countries (2015-2020) ($ Millions)
Table 31. Americas DNA Vaccines Value Market Share by Countries (2015-2020)
Table 32. Americas DNA Vaccines Consumption by Type (2015-2020) (K Doses)
Table 33. Americas DNA Vaccines Consumption Market Share by Type (2015-2020)
Table 34. Americas DNA Vaccines Consumption by Application (2015-2020) (K Doses)
Table 35. Americas DNA Vaccines Consumption Market Share by Application (2015-2020)
Table 36. APAC DNA Vaccines Consumption by Countries (2015-2020) (K Doses)
Table 37. APAC DNA Vaccines Consumption Market Share by Countries (2015-2020)
Table 38. APAC DNA Vaccines Value by Regions (2015-2020) ($ Millions)
Table 39. APAC DNA Vaccines Value Market Share by Regions (2015-2020)
Table 40. APAC DNA Vaccines Consumption by Type (2015-2020) (K Doses)
Table 41. APAC DNA Vaccines Consumption Market Share by Type (2015-2020)
Table 42. APAC DNA Vaccines Consumption by Application (2015-2020) (K Doses)
Table 43. APAC DNA Vaccines Consumption Market Share by Application (2015-2020)
Table 44. Europe DNA Vaccines Consumption by Countries (2015-2020) (K Doses)
Table 45. Europe DNA Vaccines Consumption Market Share by Countries (2015-2020)
Table 46. Europe DNA Vaccines Value by Countries (2015-2020) ($ Millions)
Table 47. Europe DNA Vaccines Value Market Share by Countries (2015-2020)
Table 48. Europe DNA Vaccines Consumption by Type (2015-2020) (K Doses)
Table 49. Europe DNA Vaccines Consumption Market Share by Type (2015-2020)
Table 50. Europe DNA Vaccines Consumption by Application (2015-2020) (K Doses)
Table 51. Europe DNA Vaccines Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa DNA Vaccines Consumption by Countries (2015-2020) (K Doses)
Table 53. Middle East & Africa DNA Vaccines Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa DNA Vaccines Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa DNA Vaccines Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa DNA Vaccines Consumption by Type (2015-2020) (K Doses)
Table 57. Middle East & Africa DNA Vaccines Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa DNA Vaccines Consumption by Application (2015-2020) (K Doses)
Table 59. Middle East & Africa DNA Vaccines Consumption Market Share by Application (2015-2020)
Table 60. DNA Vaccines Distributors List
Table 61. DNA Vaccines Customer List
Table 62. Global DNA Vaccines Consumption Forecast by Countries (2021-2025) (K Doses)
Table 63. Global DNA Vaccines Consumption Market Forecast by Regions
Table 64. Global DNA Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global DNA Vaccines Value Market Share Forecast by Regions
Table 66. Global DNA Vaccines Consumption Forecast by Type (2021-2025) (K Doses)
Table 67. Global DNA Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global DNA Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global DNA Vaccines Value Market Share Forecast by Type (2021-2025)
Table 70. Global DNA Vaccines Consumption Forecast by Application (2021-2025) (K Doses)
Table 71. Global DNA Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global DNA Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global DNA Vaccines Value Market Share Forecast by Application (2021-2025)
Table 74. Merck Product Offered
Table 75. Merck DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Merck Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Product Offered
Table 80. GSK DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. GSK Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Zoties Product Offered
Table 85. Zoties DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 86. Zoties Main Business
Table 87. Zoties Latest Developments
Table 88. Zoties Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Elanco Product Offered
Table 90. Elanco DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 91. Elanco Main Business
Table 92. Elanco Latest Developments
Table 93. Elanco Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Product Offered
Table 95. Sanofi DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Sanofi Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Plumbline Life Sciences Product Offered
Table 100. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 101. Plumbline Life Sciences Main Business
Table 102. Plumbline Life Sciences Latest Developments
Table 103. Plumbline Life Sciences Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Boehringer-Ingelheim Product Offered
Table 105. Boehringer-Ingelheim Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Boehringer-Ingelheim Main Business
Table 107. Boehringer-Ingelheim Latest Developments
Table 108. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 109. Indian Immunologicals Product Offered
Table 110. Indian Immunologicals DNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 111. Indian Immunologicals Main Business
Table 112. Indian Immunologicals Latest Developments
Table 113. Indian Immunologicals Basic Information, Company Total Revenue (in $ million), DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of DNA Vaccines
Figure 2. DNA Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global DNA Vaccines Consumption Growth Rate 2015-2025 (K Doses)
Figure 5. Global DNA Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Recombinant Protein Vaccine
Figure 7. Product Picture of Gene-Based Vaccine
Figure 8. Global DNA Vaccines Consumption Market Share by Type (2015-2020)
Figure 9. Global DNA Vaccines Value Market Share by Type (2015-2020)
Figure 10. DNA Vaccines Consumed in Human
Figure 11. Global DNA Vaccines Market: Human (2015-2020) (K Doses)
Figure 12. Global DNA Vaccines Market: Human (2015-2020) ($ Millions)
Figure 13. DNA Vaccines Consumed in Animal
Figure 14. Global DNA Vaccines Market: Animal (2015-2020) (K Doses)
Figure 15. Global DNA Vaccines Market: Animal (2015-2020) ($ Millions)
Figure 16. Global DNA Vaccines Consumption Market Share by Application (2015-2020)
Figure 17. Global DNA Vaccines Value Market Share by Application (2015-2020)
Figure 18. Global DNA Vaccines Sales Market Share by Company in 2017
Figure 19. Global DNA Vaccines Sales Market Share by Company in 2019
Figure 20. Global DNA Vaccines Revenue Market Share by Company in 2017
Figure 21. Global DNA Vaccines Revenue Market Share by Company in 2019
Figure 22. Global DNA Vaccines Sale Price by Company in 2019
Figure 23. Global DNA Vaccines Consumption Market Share by Regions 2015-2020
Figure 24. Global DNA Vaccines Value Market Share by Regions 2015-2020
Figure 25. Americas DNA Vaccines Consumption 2015-2020 (K Doses)
Figure 26. Americas DNA Vaccines Value 2015-2020 ($ Millions)
Figure 27. APAC DNA Vaccines Consumption 2015-2020 (K Doses)
Figure 28. APAC DNA Vaccines Value 2015-2020 ($ Millions)
Figure 29. Europe DNA Vaccines Consumption 2015-2020 (K Doses)
Figure 30. Europe DNA Vaccines Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa DNA Vaccines Consumption 2015-2020 (K Doses)
Figure 32. Middle East & Africa DNA Vaccines Value 2015-2020 ($ Millions)
Figure 33. Americas DNA Vaccines Consumption Market Share by Countries in 2019
Figure 34. Americas DNA Vaccines Value Market Share by Countries in 2019
Figure 35. Americas DNA Vaccines Consumption Market Share by Type in 2019
Figure 36. Americas DNA Vaccines Consumption Market Share by Application in 2019
Figure 37. United States DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 38. United States DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 39. Canada DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 40. Canada DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 42. Mexico DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 43. APAC DNA Vaccines Consumption Market Share by Countries in 2019
Figure 44. APAC DNA Vaccines Value Market Share by Regions in 2019
Figure 45. APAC DNA Vaccines Consumption Market Share by Type in 2019
Figure 46. APAC DNA Vaccines Consumption Market Share by Application in 2019
Figure 47. China DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 48. China DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 49. Japan DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 50. Japan DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 51. Korea DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 52. Korea DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 54. Southeast Asia DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. India DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 56. India DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Australia DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 58. Australia DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. Europe DNA Vaccines Consumption Market Share by Countries in 2019
Figure 60. Europe DNA Vaccines Value Market Share by Countries in 2019
Figure 61. Europe DNA Vaccines Consumption Market Share by Type in 2019
Figure 62. Europe DNA Vaccines Consumption Market Share by Application in 2019
Figure 63. Germany DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 64. Germany DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 65. France DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 66. France DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 67. UK DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 68. UK DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 69. Italy DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 70. Italy DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. Russia DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 72. Russia DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. Spain DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 74. Spain DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa DNA Vaccines Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa DNA Vaccines Value Market Share by Countries in 2019
Figure 77. Middle East & Africa DNA Vaccines Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa DNA Vaccines Consumption Market Share by Application in 2019
Figure 79. Egypt DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 80. Egypt DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 82. South Africa DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 83. Israel DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 84. Israel DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 86. Turkey DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries DNA Vaccines Consumption Growth 2015-2020 (K Doses)
Figure 88. GCC Countries DNA Vaccines Value Growth 2015-2020 ($ Millions)
Figure 89. Global DNA Vaccines Consumption Growth Rate Forecast (2021-2025) (K Doses)
Figure 90. Global DNA Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 92. Americas DNA Vaccines Value 2021-2025 ($ Millions)
Figure 93. APAC DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 94. APAC DNA Vaccines Value 2021-2025 ($ Millions)
Figure 95. Europe DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 96. Europe DNA Vaccines Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 98. Middle East & Africa DNA Vaccines Value 2021-2025 ($ Millions)
Figure 99. United States DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 100. United States DNA Vaccines Value 2021-2025 ($ Millions)
Figure 101. Canada DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 102. Canada DNA Vaccines Value 2021-2025 ($ Millions)
Figure 103. Mexico DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 104. Mexico DNA Vaccines Value 2021-2025 ($ Millions)
Figure 105. Brazil DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 106. Brazil DNA Vaccines Value 2021-2025 ($ Millions)
Figure 107. China DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 108. China DNA Vaccines Value 2021-2025 ($ Millions)
Figure 109. Japan DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 110. Japan DNA Vaccines Value 2021-2025 ($ Millions)
Figure 111. Korea DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 112. Korea DNA Vaccines Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 114. Southeast Asia DNA Vaccines Value 2021-2025 ($ Millions)
Figure 115. India DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 116. India DNA Vaccines Value 2021-2025 ($ Millions)
Figure 117. Australia DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 118. Australia DNA Vaccines Value 2021-2025 ($ Millions)
Figure 119. Germany DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 120. Germany DNA Vaccines Value 2021-2025 ($ Millions)
Figure 121. France DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 122. France DNA Vaccines Value 2021-2025 ($ Millions)
Figure 123. UK DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 124. UK DNA Vaccines Value 2021-2025 ($ Millions)
Figure 125. Italy DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 126. Italy DNA Vaccines Value 2021-2025 ($ Millions)
Figure 127. Russia DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 128. Russia DNA Vaccines Value 2021-2025 ($ Millions)
Figure 129. Spain DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 130. Spain DNA Vaccines Value 2021-2025 ($ Millions)
Figure 131. Egypt DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 132. Egypt DNA Vaccines Value 2021-2025 ($ Millions)
Figure 133. South Africa DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 134. South Africa DNA Vaccines Value 2021-2025 ($ Millions)
Figure 135. Israel DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 136. Israel DNA Vaccines Value 2021-2025 ($ Millions)
Figure 137. Turkey DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 138. Turkey DNA Vaccines Value 2021-2025 ($ Millions)
Figure 139. GCC Countries DNA Vaccines Consumption 2021-2025 (K Doses)
Figure 140. GCC Countries DNA Vaccines Value 2021-2025 ($ Millions)
Figure 141. Merck DNA Vaccines Market Share (2018-2020)
Figure 142. GSK DNA Vaccines Market Share (2018-2020)
Figure 143. Zoties DNA Vaccines Market Share (2018-2020)
Figure 144. Elanco DNA Vaccines Market Share (2018-2020)
Figure 145. Sanofi DNA Vaccines Market Share (2018-2020)
Figure 146. Plumbline Life Sciences DNA Vaccines Market Share (2018-2020)
Figure 147. Boehringer-Ingelheim DNA Vaccines Market Share (2018-2020)
Figure 148. Indian Immunologicals DNA Vaccines Market Share (2018-2020)


★調査レポート[世界のDNAワクチン市場予測 2020年-2025年] (コード:LPI20AP8443)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のDNAワクチン市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆